300642 透景生命
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入320,919-20.01%542,809715,971654,589489,581
减:营业总成本287,294-23.12%474,804613,256514,520374,797
    其中:营业成本112,516-23.63%188,575307,574216,998164,534
               财务费用(2,163)-53.76%(4,461)(11,235)(3,978)(984)
               资产减值损失(6,880)-3,830.71%(2,323)(3,843)(3,405)(2,581)
公允价值变动收益902-80.23%11,50317,85130,5612,292
投资收益1,509-84.97%12,19018,40410,3197,513
    其中:对联营企业和合营企业的投资收益(5,764)-229.64%4,94211,9432,809(3,073)
营业利润23,569-43.20%88,363131,433180,538132,251
利润总额22,532-45.11%87,485130,664178,179130,377
减:所得税费用2,764163.95%2,7876,91717,1229,824
净利润19,768-50.58%84,697123,747161,058120,553
减:非控股权益(4,625)58.91%(4,706)(1,011)(25)--
股东净利润24,393-43.16%89,404124,758161,083120,553

市场价值指针
每股收益 (元) *0.150-42.79%0.5480.7670.9870.740
每股派息 (元) *----0.1500.2000.2500.400
每股净资产 (元) *9.2521.34%9.3138.9878.50413.960
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容